Trial of Cell Based Therapy for DMD | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Trial of Cell Based Therapy for DMD | stella

Back to Duchenne Muscular Dystrophy trials

Recruiting

Plain-English translation of NCT06692426 on ClinicalTrials.gov ↗ · Source last updated March 2026 · How we translate trials

Read our Duchenne Muscular Dystrophy research guide →

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

United States

Masonic Cancer Center, Minneapolis, Minnesota

Key details

Phase

Safety & dosing

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

Duchenne UK, Parent Project Muscular Dystrophy

Enrollment target

~8 participants

Started

March 2025

Primary completion

March 2027

View full record on ClinicalTrials.gov

Age range

18 Years and older

Last updated on clinicaltrials.gov in March 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Peter Kang, MD

Masonic Cancer Center, University of Minnesota

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.